15.04.2016 – 15:26

LifeWatch AG

EQS-Adhoc: LifeWatch AG: Annual General Meeting approves ordinary capital increase

EQS Group-Ad-hoc: LifeWatch AG / Key word(s): AGM/EGM
LifeWatch AG: Annual General Meeting approves ordinary capital increase

15.04.2016 / 15:20
Release of an ad hoc announcement pursuant to Art. 53 KR.
The issuer is solely responsible for the content of this announcement.

--------------------------------------------------------------------------------
LifeWatch: Annual General Meeting approves ordinary capital increase

Zug/Switzerland, April 15, 2016 - LifeWatch AG (SIX Swiss Exchange: LIFE), a
leading developer and provider of medical solutions and remote diagnostic
monitoring services to the digital health market, reports that today's Ordinary
Annual General Meeting approved the ordinary capital increase proposed by the
Board of Directors. 66 shareholders attended the meeting in Zurich and in total
7,935,163 votes or 58.85% of the share capital were represented. The outcomes of
the motions are summarized below:

- Approval of the Annual Report 2015 and the allocation of the balance sheet
result 2015.

- Discharge for fiscal year 2015 was granted to Patrick Schildknecht, Thomas
Rühle, Antoine Hubert, Dr. Stephan Rietiker, Mike Turchi, Stephanie Kravetz,
Dominik Aronsky, Stefan Vogt und Yair Tal.

- Elections to the Board of Directors until next Ordinary Annual General Meeting
2017

- Elected: Patrick Schildknecht, Thomas Rühle, Raymond W. Cohen, Antoine Hubert,
Robert Bider, Antoine Kohler and Jinsheng Dong, the latter as representative of
Himalaya TMT Fonds and as recommended by the Board of Directors

- Chairman of the Board of Directors: Robert Bider

- Elected as members of the Compensation Committee: Thomas Rühle, Antoine
Hubert, Raymond W. Cohen

- The Annual General Meeting did approve the proposed amendments to the Articles
of Incorporation

- Ordinary Increase of the Share Capital by a maximum of CHF 6,500,000

- Amendment of Article 3bis para. 1: This motion has been changed by the Board
of Directors to an amount of CHF 0.00 which was approved by a majority of
shareholders.

- The Annual General Meeting did not approve the agenda item 9.1, total
compensation for the Board of Directors for the financial year 2015.

- The Annual General Meeting did approve the total compensation for the Board of
Directors for the financial years 2016 and 2017.

- The Annual General Meeting approved the proposed variable compensation for the
financial year 2015 and the fixed compensation to the Executive Management Team
for the financial year 2017.

- Election of the independent proxy: Yves Endrass, Zurich

- Election of the statutory auditors: PricewaterhouseCoopers, Zurich


For Questions:
LifeWatch AG
c/o Dynamics Group, Philippe Blangey / Doris Rudischhauser
Telephone: +41 43 268 32 35 / 079 410 81 88
E-Mail:investor-relations@lifewatch.com


About LifeWatch AG

LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE),
Switzerland, is a leading healthcare technology and solutions' company,
specializing in advanced digital health systems and wireless remote diagnostic
patient monitoring services. LifeWatch's services provide physicians with
critical information to determine appropriate treatment and thereby improve
patient outcomes. LifeWatch AG has operative subsidiaries in the United States,
in Switzerland and in Israel, and is the parent company of LifeWatch Services
Inc., and LifeWatch Technologies, Ltd. LifeWatch Services, Inc. is a leading
U.S.-based provider of cardiac monitoring services and home sleep testing of
Obstructive Sleep Apnea (OSA). LifeWatch Technologies Ltd., based in Israel, is
a leading developer and manufacturer of telemedicine products. For additional
information, please visitwww.lifewatch.com.

Sign up for customized e-mail alerts and documentation requests at
http://www.irlifewatch.com/alert-service.aspx

This press release includes forward-looking statements. All statements other
than statements of historical facts contained in this press release, including
statements regarding future results of operations and financial position, the
business strategy, and plans and objectives for future operations, are
forward-looking statements. The words "believe," "may," "will," "estimate,"
"continue," "anticipate," "intend," "expect" and similar expressions are
intended to identify forward-looking statements. LifeWatch AG has based these
forward-looking statements largely on current expectations and projections about
future events and financial trends that it believes may affect the financial
condition, results of operations, business strategy, short-term and long-term
business operations and objectives, and financial needs. These forward-looking
statements are subject to a number of risks, uncertainties and assumptions. In
light of these risks, uncertainties and assumptions, the forward-looking events
and circumstances described may not occur and actual results could differ
materially and adversely from those anticipated or implied in the
forward-looking statements. All forward-looking statements are based only on
data available to LifeWatch AG at the time of the issue of this press release.
LifeWatch AG does not undertake any obligation to update any forward-looking
statements contained in this press release as a result of new information,
future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND
SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A
GENERAL CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE
AN OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN
THE UNITED STATES, OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES
OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER
THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED
WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT FROM REGISTRATION UNDER OR AN
APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES
SECURITIES LAWS. ANY PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED
STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH
AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED INFORMATION
ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL STATEMENTS OF THE
ISSUER.

End of ad hoc announcement

+++++
Additional features:

Document:http://n.eqs.com/c/fncls.ssp?u=LNUXHAFNVG
Document title: LifeWatch: Annual General Meeting approves ordinary capital
increase

--------------------------------------------------------------------------------
15.04.2016 News transmitted by EQS Schweiz AG. www.eqs.com - news archive:
http://switzerland.eqs.com/de/News

The issuer is responsible for the contents of the release.
--------------------------------------------------------------------------------

Language: English

Company:  LifeWatch AG

          Baarerstrasse 139

          6300  Zug

          Switzerland

Phone:    +41 41 728 67 78

Internet: www.lifewatch.com

ISIN:     CH0012815459

Valor:    811189

Listed:   Regulated Unofficial Market in Berlin, Stuttgart; Open Market in
Frankfurt ; SIX


End of News EQS Group News Service
--------------------------------------------------------------------------------
454779  15.04.2016